what are the risks of glp-1 drugs Medications Infographic GLP-1 Genetics: How Genes Affect

How will care be coordinated across medical, nutrition and therapy providers

GLP-1s have been used to treat T2D since 2005, said Chris Schott, a senior analyst covering the U.S

This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code provided in analysis specifications

Some GLP-1 drugs are given by self-injection, while others are in pill form

DOI: Published online: May 1, 2025 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 2 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Jae Hyun Bae Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

May have higher risk of GI or metabolic side effects